ArticleProceedings of the National Academy of Sciences of the United States of America1999

Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.

B Shan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.